vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and NELNET INC (NNI). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $33.5M, roughly 1.9× NELNET INC). NELNET INC runs the higher net margin — 172.3% vs -70.9%, a 243.2% gap on every dollar of revenue. On growth, NELNET INC posted the faster year-over-year revenue change (79.6% vs 8.1%). NELNET INC produced more free cash flow last quarter ($396.7M vs $-1.8M). Over the past eight quarters, NELNET INC's revenue compounded faster (62.0% CAGR vs 17.7%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Nelnet, Inc. is a United States–based conglomerate that primarily focuses on financial services including student and consumer loan origination and servicing. Additionally, the company operates an investing arm, an internet bank and has a 26% stake in Allo Fiber, a cable and internet provider. The company is headquartered in Lincoln, Nebraska.
CTKB vs NNI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $33.5M |
| Net Profit | $-44.1M | $57.8M |
| Gross Margin | 52.9% | 50.5% |
| Operating Margin | -9.0% | — |
| Net Margin | -70.9% | 172.3% |
| Revenue YoY | 8.1% | 79.6% |
| Net Profit YoY | -557.1% | -8.5% |
| EPS (diluted) | — | $1.62 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $33.5M | ||
| Q3 25 | $52.3M | $23.2M | ||
| Q2 25 | $45.6M | $26.1M | ||
| Q1 25 | $41.5M | $24.7M | ||
| Q4 24 | $57.5M | $18.7M | ||
| Q3 24 | $51.5M | $16.6M | ||
| Q2 24 | $46.6M | $14.9M | ||
| Q1 24 | $44.9M | $12.8M |
| Q4 25 | $-44.1M | $57.8M | ||
| Q3 25 | $-5.5M | $106.7M | ||
| Q2 25 | $-5.6M | $181.5M | ||
| Q1 25 | $-11.4M | $82.6M | ||
| Q4 24 | $9.6M | $63.2M | ||
| Q3 24 | $941.0K | $2.4M | ||
| Q2 24 | $-10.4M | $45.1M | ||
| Q1 24 | $-6.2M | $73.4M |
| Q4 25 | 52.9% | 50.5% | ||
| Q3 25 | 52.7% | 29.6% | ||
| Q2 25 | 52.3% | 29.8% | ||
| Q1 25 | 48.6% | 30.5% | ||
| Q4 24 | 58.5% | 13.7% | ||
| Q3 24 | 56.3% | 0.1% | ||
| Q2 24 | 54.6% | 27.3% | ||
| Q1 24 | 51.3% | 15.3% |
| Q4 25 | -9.0% | — | ||
| Q3 25 | -17.6% | — | ||
| Q2 25 | -23.3% | — | ||
| Q1 25 | -36.1% | — | ||
| Q4 24 | 5.2% | 97.7% | ||
| Q3 24 | -8.2% | -13.4% | ||
| Q2 24 | -18.3% | 88.0% | ||
| Q1 24 | -23.9% | — |
| Q4 25 | -70.9% | 172.3% | ||
| Q3 25 | -10.5% | 460.5% | ||
| Q2 25 | -12.2% | 694.9% | ||
| Q1 25 | -27.5% | 334.4% | ||
| Q4 24 | 16.8% | 338.2% | ||
| Q3 24 | 1.8% | 14.4% | ||
| Q2 24 | -22.4% | 303.6% | ||
| Q1 24 | -13.8% | 574.4% |
| Q4 25 | — | $1.62 | ||
| Q3 25 | — | $2.94 | ||
| Q2 25 | — | $4.97 | ||
| Q1 25 | — | $2.26 | ||
| Q4 24 | — | $1.74 | ||
| Q3 24 | — | $0.07 | ||
| Q2 24 | — | $1.23 | ||
| Q1 24 | — | $1.98 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $296.0M |
| Total DebtLower is stronger | — | $7.8B |
| Stockholders' EquityBook value | $341.7M | $3.7B |
| Total Assets | $461.5M | $14.1B |
| Debt / EquityLower = less leverage | — | 2.11× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $296.0M | ||
| Q3 25 | $93.3M | $216.4M | ||
| Q2 25 | $75.5M | $225.8M | ||
| Q1 25 | $95.3M | $220.5M | ||
| Q4 24 | $98.7M | $194.5M | ||
| Q3 24 | $162.3M | $219.7M | ||
| Q2 24 | $177.9M | $145.5M | ||
| Q1 24 | $168.8M | $179.7M |
| Q4 25 | — | $7.8B | ||
| Q3 25 | — | $7.8B | ||
| Q2 25 | — | $7.9B | ||
| Q1 25 | — | $8.7B | ||
| Q4 24 | — | $8.3B | ||
| Q3 24 | — | $8.9B | ||
| Q2 24 | — | $9.6B | ||
| Q1 24 | — | $10.6B |
| Q4 25 | $341.7M | $3.7B | ||
| Q3 25 | $378.6M | $3.7B | ||
| Q2 25 | $377.6M | $3.6B | ||
| Q1 25 | $379.6M | $3.4B | ||
| Q4 24 | $395.7M | $3.3B | ||
| Q3 24 | $385.5M | $3.3B | ||
| Q2 24 | $389.1M | $3.3B | ||
| Q1 24 | $392.6M | $3.3B |
| Q4 25 | $461.5M | $14.1B | ||
| Q3 25 | $494.9M | $13.9B | ||
| Q2 25 | $493.3M | $13.7B | ||
| Q1 25 | $482.6M | $14.2B | ||
| Q4 24 | $499.5M | $13.8B | ||
| Q3 24 | $491.2M | $14.1B | ||
| Q2 24 | $483.7M | $14.5B | ||
| Q1 24 | $492.1M | $15.4B |
| Q4 25 | — | 2.11× | ||
| Q3 25 | — | 2.14× | ||
| Q2 25 | — | 2.21× | ||
| Q1 25 | — | 2.53× | ||
| Q4 24 | — | 2.48× | ||
| Q3 24 | — | 2.72× | ||
| Q2 24 | — | 2.90× | ||
| Q1 24 | — | 3.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $423.0M |
| Free Cash FlowOCF − Capex | $-1.8M | $396.7M |
| FCF MarginFCF / Revenue | -2.9% | 1183.0% |
| Capex IntensityCapex / Revenue | 1.6% | 78.2% |
| Cash ConversionOCF / Net Profit | — | 7.32× |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $663.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $423.0M | ||
| Q3 25 | $-3.9M | $112.4M | ||
| Q2 25 | $108.0K | $81.8M | ||
| Q1 25 | $-125.0K | $91.2M | ||
| Q4 24 | $2.0M | $662.9M | ||
| Q3 24 | $13.2M | $137.0M | ||
| Q2 24 | $6.2M | $133.8M | ||
| Q1 24 | $4.0M | $211.6M |
| Q4 25 | $-1.8M | $396.7M | ||
| Q3 25 | $-4.6M | $100.8M | ||
| Q2 25 | $-1.5M | $78.1M | ||
| Q1 25 | $-974.0K | $87.8M | ||
| Q4 24 | $1.1M | $642.0M | ||
| Q3 24 | $12.2M | $132.6M | ||
| Q2 24 | $5.2M | $123.1M | ||
| Q1 24 | $3.4M | $188.3M |
| Q4 25 | -2.9% | 1183.0% | ||
| Q3 25 | -8.7% | 435.0% | ||
| Q2 25 | -3.2% | 299.0% | ||
| Q1 25 | -2.3% | 355.6% | ||
| Q4 24 | 1.9% | 3438.0% | ||
| Q3 24 | 23.7% | 797.9% | ||
| Q2 24 | 11.0% | 829.2% | ||
| Q1 24 | 7.6% | 1473.7% |
| Q4 25 | 1.6% | 78.2% | ||
| Q3 25 | 1.3% | 50.4% | ||
| Q2 25 | 3.5% | 14.2% | ||
| Q1 25 | 2.0% | 13.7% | ||
| Q4 24 | 1.6% | 111.9% | ||
| Q3 24 | 2.0% | 26.7% | ||
| Q2 24 | 2.3% | 71.5% | ||
| Q1 24 | 1.3% | 181.7% |
| Q4 25 | — | 7.32× | ||
| Q3 25 | — | 1.05× | ||
| Q2 25 | — | 0.45× | ||
| Q1 25 | — | 1.10× | ||
| Q4 24 | 0.21× | 10.50× | ||
| Q3 24 | 14.05× | 57.39× | ||
| Q2 24 | — | 2.97× | ||
| Q1 24 | — | 2.88× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
NNI
Segment breakdown not available.
